Purpose: To evaluate the safety to the retina of a light-delivery device used to irradiate a light-adjustable intraocular lens (IOL) after implantation in a rabbit model.
Setting: John A. Moran Eye Center, University of Utah, Salt Lake City, Utah, USA.
Methods: In this study, rabbits had phacoemulsification with implantation of an ultraviolet (UV)-filtering light-adjustable IOL (study IOL) in 1 eye and a custom-made silicone IOL without a UV filter (control IOL) in the opposite eye. The study IOLs were irradiated at 1.0, 2.0, 3.0, and 5.0 times the expected maximum UV irradiation doses and the control IOLs, at 0.3, 0.6, 1.0, and 2.0 times. One week after irradiation, slitlamp and fundus (indirect ophthalmoscopy) examinations were performed. The rabbits were then humanely killed and their eyes enucleated and processed for histopathology.
Results: The 16 eyes with the study IOL (with UV filter) showed no signs of corneal, anterior segment, or retinal toxicity on histopathologic evaluation. The 16 eyes with the control IOL (no UV filter) also showed no signs of corneal or anterior segment toxicity; however, 3 eyes receiving the higher radiation doses had focal areas of retinal damage consistent with laser burn.
Conclusion: Pigmented rabbit eyes with a light-adjustable IOL with a UV filter showed no signs of retina toxicity after near-UV light exposure up to 5 times the expected maximum treatment dosage.
Financial Disclosure: No author has a financial or proprietary interest in any material or method mentioned. Additional disclosures are found in the footnotes.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jcrs.2010.02.018 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Postoperative guidelines following pediatric cataract and glaucoma surgeries: a survey of preferred surgeon instructions.
J AAPOS
January 2025
Johns Hopkins University Wilmer Eye Institute, Baltimore, Maryland. Electronic address:
Background Recommendations regarding long-term postoperative activity are intended to prevent adverse events, but no common policy or best practice exists among ophthalmologists for pediatric patients. We surveyed ophthalmologists on their postoperative guidelines after the one-month postoperative period following childhood cataract and glaucoma surgeries. Methods A 28-question anonymous Qualtrics survey was distributed via listservs and social media.
View Article and Find Full Text PDFInnovative Polymeric Biomaterials for Intraocular Lenses in Cataract Surgery.
J Funct Biomater
December 2024
Department of Surgery, Division of Ophthalmology, University of Sherbrooke, Sherbrooke, QC J1G 2E8, Canada.
Intraocular lenses (IOLs) play a pivotal role in restoring vision following cataract surgery. The evolution of polymeric biomaterials has been central to addressing challenges such as biocompatibility, optical clarity, mechanical stability, and resistance to opacification. This review explores essential requirements for IOL biomaterials, emphasizing their ability to mitigate complications like posterior capsule opacification (PCO) and dysphotopsias while maintaining long-term durability and visual quality.
View Article and Find Full Text PDFManagement and toxicological analysis of ocular hypertension after EyeCee ONE intraocular lens implantation: a case series.
BMC Ophthalmol
December 2024
Department 3, 15-20 National Vision Hospital, IHU FOReSIGHT, 28 rue de Charenton, Paris, 75012, France.
Background: The EyeCee ONE intraocular lens (Nidek, Gamagori, Japan) has been withdrawn from the market due to a high number of reports of severe ocular hypertension (OHT) following phacoemulsification with implantation of this intraocular lens (IOL). In this case series, we report the results of a toxicological analysis and the surgical management of five patients with severe OHT following the implantation of defective EyeCee ONE IOLs during cataract surgery.
Cases Presentation: Five patients developed early, severe OHT refractory to maximal medical therapy following uneventful phacoemulsification (PCE) cataract surgery with implantation of an EyeCee ONE IOL from a defective lot.
Canaloplasty and Trabeculotomy Using the OMNI Surgical System in Three Patients with Angle Closure: A Case Series.
J Curr Glaucoma Pract
October 2024
Department of Ophthalmology, University Hospital Southampton, Southampton, Hampshire, England, United Kingdom.
Aim And Background: The OMNI surgical system allows for 360° canaloplasty and trabeculotomy for patients with glaucoma, either as a standalone procedure or in combination with cataract surgery. There is currently limited evidence on its use in forms of angle-closure glaucoma, though other microinvasive glaucoma surgeries have been used. We present three patients with angle closure who underwent the procedure.
View Article and Find Full Text PDFClinical Evaluation of Violet Light Filtration and High-Resolution Lathing on a Diffractive Extended Depth of Focus IOL.
Ophthalmol Ther
December 2024
Research Department, Empire Eye and Laser Center, Bakersfield, CA, USA.
Introduction: This study is a prospective, randomized, subject/evaluator-masked clinical trial in a single-center clinical setting. The purpose of the study is to compare the clinical performance of Tecnis Symfony Optiblue IOL (models ZXR00V and ZXW150) with violet light filter (VLF) and manufacturing improvements versus Tecnis Symfony IOL (models ZXR00 and ZXT150) with ultraviolet light filter (UVF) in patients undergoing cataract surgery.
Methods: Patients with cataracts aged ≥ 22 years were randomly assigned 1:1 to bilateral implantation with ZXR00V/ZXW150 (VLF group) or ZXR00/ZXT150 (UVF group).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!